Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Medtronic makes yet another move in China, ones of the fastest-growing medtech markets in the world, with a $66.2 million investment in cardiovascular devices maker LifeTech Scientific Corp.
A jury will begin hearing evidence today in a nasty patent spat over fractional flow reserve technology between St. Jude Medical and Volcano Corp.
With patients and physicians submitting adverse events to the FDA and law firms soliciting patients with injuries, the metal-on-metal hip legal storm may be headed to Smith & Nephew next, even though the company’s Birmingham hip resurfacing systems have yet to undergo a recall.